SANDOZ SUNITINIB

Identification of Sandoz Sunitinib

No description

Google image searchProduct monograph

Active ingredient

sunitinib, 12.5 MG

DIN: 02532840

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 24-MAY-2023

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX01 — SUNITINIB (ATC/DDD)

Reference brand drug: Sutent

External Links for Sandoz Sunitinib

Search on Google

• Sandoz Sunitinib side effects
• Sandoz Sunitinib dosage
• sunitinib side effects
• sunitinib dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find sandoz sunitinib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.